Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Purnell

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Sensors (Basel, Switzerland)|July 8, 2023
Scheduling Sparse LEO Satellite Transmissions for Remote Water Level MonitoringGarrett Kinman, Željko Žilić, David Purnell
International Journal of Cancer|July 15, 2004
High BRAF mutation frequency does not characterize all melanocytic tumor typesGerald Saldanha, David Purnell, Alan Fletcher, et al.
Histopathology|July 26, 2022
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancerAyaka Katayama, Jane Starczynski, Michael S Toss, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Sensors (Basel, Switzerland)|July 8, 2023
Scheduling Sparse LEO Satellite Transmissions for Remote Water Level MonitoringGarrett Kinman, Željko Žilić, David Purnell
International Journal of Cancer|July 15, 2004
High BRAF mutation frequency does not characterize all melanocytic tumor typesGerald Saldanha, David Purnell, Alan Fletcher, et al.
Histopathology|July 26, 2022
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancerAyaka Katayama, Jane Starczynski, Michael S Toss, et al.
Pageof 1